特利加压素注射液治疗食管胃静脉曲张出血成本-效用分析

范长生, 吴久鸿

中国药学杂志 ›› 2017, Vol. 52 ›› Issue (9) : 782-786.

PDF(1149 KB)
PDF(1149 KB)
中国药学杂志 ›› 2017, Vol. 52 ›› Issue (9) : 782-786. DOI: 10.11669/cpj.2017.09.015
论著

特利加压素注射液治疗食管胃静脉曲张出血成本-效用分析

  • 范长生1, 吴久鸿2*
作者信息 +

Cost-Utility of Terlypressin in the Treatment of Esophageal and Gastric Variceal Bleeding

  • FAN Chang-sheng1, WU Jiu-hong2*
Author information +
文章历史 +

摘要

目的 对特利加压素与生长抑素治疗食管胃静脉曲张出血进行成本-效用分析,比较2种药物的经济性。方法 构建1个出血、不出血、再次出血、死亡4个疾病状态的离散仿真模拟模型,模型的转换概率来源于对文献的Meta分析;用于计算质量生命年各个状态的健康效用值来源文献,成本数据来源医疗机构采集的数据分析。对基础分析的结果采用单因敏感性分析。结果 特利加压素与生长抑素相比,治疗食管胃静脉曲张出血每多获得1个质量生命年的成本为65 478.84元;敏感性分析结果显示,每多获得1个质量生命年的成本最高为110 289.46元,低于3倍人均GDP可接受标准。若采用药物说明书中用药时间计算的成本做敏感性分析,则存在成本较低,效果较好的情况。结论 同生长抑素相比,特利加压素治疗食管胃静脉曲张出血具有经济性。

Abstract

OBJECTIVE To evaluate the cost-utility of terlypressin compared with somatostatin in the treatment of esophageal and gastric variceal bleeding(EGVB) in China. METHODS A discrete event simulation model was created with four transition states:bleeding,no bleeding,rebleeding,and death. Transition probability of the model is derived from Meta analysis of the published literature. Used to calculate the quality of life in transition states health utility value source of literature. Cost data was sourced from (the listing price) of medical institutions. One-way sensitivity analyses were performed.RESULTS In the base case scenario, results showed that terlypressin was more costly and more effective compared with somatostatin, and that incremental cost-utility ratios were 65 478.84 Yuan/QALY. Sensitivity analyses showed that the model was robust, and that all incremental cost-utility ratios were below 110 289.46 Yuan/QALYs,which is far less than three times gross domestic product (GDP) per capita in China. If using the treatment duration in the instructions to calculate drug costs in the sensitivity analysis, treatment with terlypression has lower cost and better effectiveness.CONCLUSION The model indicates that terlypressin is most likely to be cost-effective versus somatostatin.

关键词

特利加压素 / 生长抑素 / 食管胃底静脉曲张出血 / 成本-效用分析

Key words

terlypressin / somatostatin / esophageal and gastric variceal bleeding(EGVB) / cost-utility analysis

引用本文

导出引用
范长生, 吴久鸿. 特利加压素注射液治疗食管胃静脉曲张出血成本-效用分析[J]. 中国药学杂志, 2017, 52(9): 782-786 https://doi.org/10.11669/cpj.2017.09.015
FAN Chang-sheng, WU Jiu-hong. Cost-Utility of Terlypressin in the Treatment of Esophageal and Gastric Variceal Bleeding[J]. Chinese Pharmaceutical Journal, 2017, 52(9): 782-786 https://doi.org/10.11669/cpj.2017.09.015
中图分类号: R956   

参考文献

[1] D AMICO G, DE FRANCHIS R. Upper digestive bleeding incirrhosis. Post-therapeuticoutcome and prognostic indicators[J].Hepatology, 2003, 38(3):599-612.
[2] SCHEPIS F, CAMMA C, NICEFORO D, et al.Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection?[J] . Hepatology, 2001, 33(2):333-338.
[3] BENDTSEN F, KRAG A, MOILER S.Treatment of acute varicealbleeding[J].Dig Liver Dis, 2008, 40(5):328-336.
[4] D AMICO G, LUCA A.TIPS is a cost effective alternative to surgicalshunt as a rescue therapy fur prevention of recurrent bleeding fromesophageal varices[J]. J Hepatol, 2008, 48(3):387-390.
[5] Digestive branch of Chinese Medical Association, et al. Liver cirrhosis portal hypertension with esophageal gastric varices bleeding prevention and control of consensus (2008, Hangzhou) [J]. J Intern Med Concepts Prac(内科理论与实践), 2009, 4(2):152-158.
[6] HANSEN E F, STRANDBERG C, HOJGAARD L, et al. Splanchnic haemodynanics after intravenous tedipressin in anaesthetized healthypigs[J].J Hepatology, 1999, 30(3):503-510.
[7] KISZKA-KANEWITZ M, HENRIEKSEN J H, HANSEN E F, et al. Effect ofterlipressin on blood volume distribution in patients with cirrhosis[J].Scandinavian J Gastroetenterol, 2004, 39(5):486-492.
[8] YOUNOSSI Z M, BOPARAI N, MCCORMICK M, et al. Assessmentof utilities and health-related quality of life in patients withchronic liver disease[J]. Am J Gastroenterol, 2001, 96(2):579-583.
[9] CHEN Y Y. Comparision the effect of terlipressin vs octreotide on treatment of ruptured esophageal gastric varices bleeding [J]. China Med Pharmacy(中国医药科学), 2012, 11(2):61-68.
[10] WU Y, CHENG C S. Comparision the effect and safety of terlipressin vs octreotide on treatment ofupper gastrointestinal hemorrhage in liver cirrhosis[J]. Chin J Clin Gastroenterol(临床消化病杂志), 2015, 27(1):23-26.
[11] PEDRETTI G, ELIA G, CALZETTI C, et al. Octreotide versus terlipressin in acute varicealhemorrhage in liver cirrhosis. Emergency control and prevention of early rebleeding[J]. Clin Invest, 1994, 72(9):653-659.
[12] SEO Y S, PARK S Y, KIM M Y, et al. Lack of difference among terlipressin, somatostatin, and octreotidein the control of acute gastroesophageal variceal hemorrhage[J]. Hepatology, 2014, 60(3):954-963.
[13] ZHENG X. Clinical observation of terlipressin for treatment of esophagogastricvarices complicated in portal hypertension due to liver cirrhosis[J]. J Taishan Med College(泰山医学院学报), 2014, 35(8):757-759.
[14] LIU S, XU J Y, HOU X H, et al. Terlipressin vs stilamin for the treatment of acute bleeding from esophageal varices[J]. Chin J Gastroenterol Hepatol(胃肠病学和肝病学杂志), 2000, 9(1):60-62.
[15] LV F B, WANG W J, WANG L. Clinical observation of terlipressinon treatment of ruptured esophageal gastric varices bleeding[J]. Chin J Ethnomed Ethnopharm(中国民族民间医药), 2013, 22(10):87-89.
[16] FEU F, RUIZDEL ARBOL L, BANARES R, et al. Doubleblindrandomized controlled trial comparing terlipressin andsomatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group[J]. Gastroenterology, 1996, 111(5):1291-1299.
[17] SEO Y S, UM S H, HYUN J J, et al. Aprospective study comparing the efficacy of early administrationof terlipressin and somatostatin for the control of acute varicealbleeding in patients with cirrhosis[J]. Korean J Hepatol, 2006, 12(3):373-384.
[18] WALKER S, KREICHGAUER H, BODE J. Terlipressin vs somatostatin in bleeding esophageal varices: a controlled double blind study[J]. Hepatology, 1992, 15(6):1023-1230.
[19] GUO L Y, LV D M. Terlipressin in the treatment of acute esophageal varices rupture hemorrhage clinical study [J]. Chongqing Med(重庆医学), 2012, 11(31):3312-3313.
[20] HONG X F, TONG X P, ZHU X X, et al. Terlipressin treatment of 39 cases of ruptured esophageal gastric varices bleeding[J]. Her Med(医药导报), 2014, 33(2):219-221.
PDF(1149 KB)

Accesses

Citation

Detail

段落导航
相关文章

/